<DOC>
	<DOC>NCT03089112</DOC>
	<brief_summary>A Randomized, Open-label, Crossover Study to Investigate the Pharmacokinetic drug interactions and the Safety between HGP1607 and HGP1501 in Healthy Male Volunteers</brief_summary>
	<brief_title>Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501</brief_title>
	<detailed_description />
	<criteria>1.age 19~40 years 2.The result of BMI is not less than 19 kg/m2 , no more than 28 kg/m2 3.Subjects who have ability to comprehend the objectives, contents of study and property of study drug before participating in trial and have willingness to sign of informed consent in writing 1. Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in digestive system, neuropsychiatric system, endocrine system, liver, cardiovascular system 2. Subjects who judged ineligible by the investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>